Bank of New York Mellon’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.4K | Hold |
19,058
| – | – | ﹤0.01% | 4072 |
|
2025
Q1 | $28.6K | Hold |
19,058
| – | – | ﹤0.01% | 4058 |
|
2024
Q4 | $95.9K | Sell |
19,058
-1
| -0% | -$5 | ﹤0.01% | 4012 |
|
2024
Q3 | $154K | Hold |
19,059
| – | – | ﹤0.01% | 3948 |
|
2024
Q2 | $110K | Hold |
19,059
| – | – | ﹤0.01% | 4016 |
|
2024
Q1 | $227K | Sell |
19,059
-1,646
| -8% | -$19.6K | ﹤0.01% | 3887 |
|
2023
Q4 | $387K | Sell |
20,705
-13,067
| -39% | -$244K | ﹤0.01% | 3692 |
|
2023
Q3 | $320K | Sell |
33,772
-355
| -1% | -$3.37K | ﹤0.01% | 3770 |
|
2023
Q2 | $488K | Sell |
34,127
-96
| -0.3% | -$1.37K | ﹤0.01% | 3604 |
|
2023
Q1 | $527K | Hold |
34,223
| – | – | ﹤0.01% | 3468 |
|
2022
Q4 | $460K | Sell |
34,223
-106
| -0.3% | -$1.42K | ﹤0.01% | 3578 |
|
2022
Q3 | $470K | Buy |
34,329
+8,837
| +35% | +$121K | ﹤0.01% | 3592 |
|
2022
Q2 | $289K | Sell |
25,492
-33
| -0.1% | -$374 | ﹤0.01% | 3902 |
|
2022
Q1 | $340K | Sell |
25,525
-5,378
| -17% | -$71.6K | ﹤0.01% | 3941 |
|
2021
Q4 | $543K | Buy |
30,903
+4,867
| +19% | +$85.5K | ﹤0.01% | 3755 |
|
2021
Q3 | $826K | Buy |
26,036
+3,868
| +17% | +$123K | ﹤0.01% | 3505 |
|
2021
Q2 | $1.9M | Buy |
+22,168
| New | +$1.9M | ﹤0.01% | 3010 |
|